Key result
Liposomal bupivacaine transversus abdominis plane block significantly reduced intravenous and total postoperative narcotic use compared with bupivacaine TAP block, pain pump, or no intervention.
Why the study?
Does liposomal bupivacaine transversus abdominis plane block reduce postoperative narcotic use in women undergoing unilateral delayed deep inferior epigastric perforator flap reconstruction?
RCT (n=27)
Blinded
Randomized to one of three groups
Does liposomal bupivacaine transversus abdominis plane block reduce postoperative narcotic use in women undergoing unilateral delayed deep inferior epigastric perforator flap reconstruction?
Liposomal bupivacaine transversus abdominis plane block significantly reduces postoperative narcotic use and time to ambulation in women undergoing abdominally based autologous breast reconstruction.
Answers are grounded in this paper and cite their sources.
Supports liposomal bupivacaine TAP blocks to minimize opioids after DIEP reconstruction; extends regional anesthesia evidence in autologous breast reconstruction.
Effective postsurgical analgesia is a critical aspect of patient recovery. The goal of this prospective, randomized, controlled, blinded study was to examine the effect that liposomal bupivacaine delivered by means of a transversus abdominis plane block has on pain control in women undergoing unilateral deep inferior epigastric perforator flap reconstruction. Institutional review board approval was granted for this prospective study. Patients were eligible if they were undergoing unilateral, delayed deep inferior epigastric perforator flap reconstruction. Patients were randomized to one of three groups: liposomal bupivacaine transversus abdominis plane block, or bupivacaine pain pump. Charts were reviewed for demographics, length of stay, and postoperative narcotic use. There were eight patients in the liposomal bupivacaine and bupivacaine transversus abdominis plane block groups and five patients in the pain pump group. A retrospective cohort of six patients who did not receive any intervention was included. Patients who received a liposomal bupivacaine transversus abdominis plane block used statistically significantly less intravenous and total postoperative narcotics in milligrams and milligrams per kilogram per day compared with all other cohorts. They were able to get out of bed at an earlier time point. Overall hospital costs were similar among the groups. This is the first study to investigate liposomal bupivacaine delivered as a transversus abdominis plane block in a prospective, randomized, blinded study in women undergoing unilateral, delayed, abdominally based autologous breast reconstruction. The authors were able to demonstrate a significant reduction in intravenous and total narcotic use when a liposomal bupivacaine transversus abdominis plane block was used. Future studies are needed to prospectively investigate the effect that liposomal bupivacaine would have on immediate and bilateral reconstructions.
No takes yet. Share an insight, caveat, or question.
Gatherwright et al. (2018) conducted an RCT in Unilateral delayed deep inferior epigastric perforator free flap reconstruction (n=27). Liposomal bupivacaine transversus abdominis plane block vs. Bupivacaine transversus abdominis plane block, bupivacaine pain pump, or no intervention was evaluated on Intravenous and total postoperative narcotic use. Liposomal bupivacaine transversus abdominis plane block significantly reduced intravenous and total postoperative narcotic use compared with bupivacaine TAP block, pain pump, or no intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: